coinmasterfreespinlevvvel| Renhe Pharmaceutical (000650.SZ): Oseltamivir Phosphate Capsules received drug registration certificate

Renhe Pharmaceutical (000650coinmasterfreespinlevvvel.SZ) announced that the company's subsidiary Jiangxi Yaodu Renhe Pharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" approved and issued by the State Food and Drug Administration for oseltamivir phosphate capsules. Oseltamivir phosphate is an influenza virus neuraminidase inhibitor (NAI) that is suitable forcoinmasterfreespinlevvvel: For the treatment of influenza A and B in adults and children 1 year old and older (oseltamivir phosphate can effectively treat influenza A and B, but there are not many clinical application data on influenza B). Patients should use it within 48 hours of first symptoms. For the prevention of influenza A and B in adults and young people aged 13 and above.

Tags:

Prev: pennfierce3sizes| Li Yunze, Director of the State Financial Supervision and Administration, met with Augustine Carstens, General Manager of the Bank for International Settlements
Next: listofblockchaingames| [Quick Hand Q1 's total revenue is 29.4 billion yuan, accounting for online marketing service revenue...